Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP0776825
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Interactions of Insulin-like Growth Factors and their Binding Proteins with Vitronectin: a structural basis for antagonist design and development. Tissue Therapies Ltd has shown that a patented combination of three biosynthetic molecules, VitroGroR, can promote tissue repair effectively. This project will use biophysical and biochemical techniques to investigate precisely how these molecules interact, and hence provide a rational basis for future developments and improvements of this exciting new therapeutic strategy. Conversely, this information would also facilitate the development of antagonists to VitroGroR complexes would provide novel opportunities to treat diseases such as cancer and atherosclerosis that involve excessive production of its component molecules.Funded Activity Details
Start Date: 01-2008
End Date: 12-2009
Funding Scheme: Linkage Projects
Funding Amount: $202,512.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Biochemistry And Cell Biology Not Elsewhere Classified | Biochemistry and Cell Biology | Biophysics
ANZSRC Socio-Economic Objective (SEO)
Skin and related disorders | Cancer and related disorders | Biological sciences |
